ac-sdkp peptide S-D-K-P peptide - PeptideSciences peptides Understanding the Ac-SDKP Peptide: An Endogenous Regulator with Therapeutic Potential

Core peptides The Ac-SDKP peptide, also known as N-acetyl-seryl-aspartyl-lysyl-proline, is a naturally occurring tetrapeptide that plays a significant role in regulating various physiological processes. This peptide has garnered considerable scientific interest due to its potent anti-inflammatory and antifibrotic properties, making it a promising candidate for therapeutic interventions in a range of conditions. Its endogenous nature and widespread distribution in mammalian organs, plasma, and urine underscore its fundamental importance in maintaining biological balance.

Origin and Synthesis of Ac-SDKP

The Ac-SDKP peptide is primarily released from its precursor, thymosin β4 (Tβ4), a 43-amino-acid peptide. This release is an enzymatic process, typically involving two successive enzymes: meprin-α and prolyl oligopeptidase (POP).Emerging Use of BPC-157 in Orthopaedic Sports Medicine - NIH Research has elucidated the intricate Tβ4-POP-Ac-SDKP axis, highlighting how the sequential hydrolysis of Tβ4 leads to the generation of this bioactive tetrapeptide. Understanding this pathway is crucial for appreciating the body's natural mechanisms for producing and utilizing Ac-SDKP. The molecular formula for Ac-SDKP is C20H34N6O7, with a molecular weight of approximately 487.51Ac-SDKPis a natural tetrapeptide with anti-inflammatory and antifibrotic properties. It has been widely distributed in mammalian organs, plasma, urine, ....

Key Properties and Functions of Ac-SDKP

The therapeutic potential of the Ac-SDKP peptide stems from its multifaceted biological activities. Its most well-documented effects include:

* Anti-inflammatory Action: Ac-SDKP demonstrates significant anti-inflammatory capabilities. It has been shown to inhibit radiation-induced endothelial reactive oxygen species (ROS) generation, suggesting a protective role in tissues subjected to oxidative stress作者：KM Kassem·2019·被引用次数：19—...peptidessuch as the antifibroticpeptide Ac-SDKP(Bernstein et al. 2011). Selective inhibition of the ACE N-domain by the phosphinicpeptideRXP 407 (Junot .... Furthermore, its anti-inflammatory activity is partially attributed to its ability to inhibit the differentiation of bone marrow stem cells into macrophagesAcSDKPis the key essentialpeptidethat regulates the antifibrotic crosstalk between miR-29s and miR-let-7s in the endothelial cells..

* Antifibrotic Effects: The peptide exhibits potent antifibrotic properties, acting to mitigate the excessive accumulation of extracellular matrix that characterizes fibrotic diseases. This effect is observed in various tissues, including the heart, aorta, and kidneysEmerging Use of BPC-157 in Orthopaedic Sports Medicine - NIH. Ac-SDKP is recognized as a key regulator of the antifibrotic crosstalk between microRNAs such as miR-29s and miR-let-7s in endothelial cellsMANP (M-Atrial Natriuretic Peptide) Reduces Blood Pressure and ....

* Cardioprotective Role: Emerging evidence points to the cardio-protective peptide Ac-SDKP having beneficial effects on cardiovascular health16 The anti-inflammatory activity ofAc-SDKPis partially attributed to inhibition of the differentiation of bone marrow stem cells into macrophages, macrophage .... It has been implicated in protecting against cardiac irradiation and may offer protection in models of cardiac injury. Its role in ACE inhibition and potential therapeutic applications in hypertension and cardiovascular diseases are areas of active investigation.

* Immunomodulatory Activity: As a naturally occurring immunomodulatory peptide, Ac-SDKP helps to regulate immune responsesStructural basis of Ac-SDKP hydrolysis by Angiotensin-I ....

* Pro-angiogenic Properties: While primarily known for its anti-inflammatory and antifibrotic roles, Ac-SDKP is also described as a pro-angiogenic peptide, suggesting a role in the formation of new blood vesselsAbstract P289: Cardio-protective Peptide Ac-SDKP is ....

* Hematopoiesis Regulation: The Ac-SDKP peptide acts as a negative regulator of hematopoietic stem cell differentiation, protecting hemopoiesis (the process of blood cell formation)Ac-SDKPis hydrolyzed by the angiotensin converting enzyme (ACE).Ac-SDKPhas anti-inflammatory and anti-fibrotic effects in heart, aorta and kidney and part of .... It inhibits the cell cycle entry of normal hematopoietic stem cells, thereby preserving the integrity of blood cell production.

Ac-SDKP in Research and Potential Applications

The scientific literature extensively explores the role of Ac-SDKP in various disease models. Studies have investigated its efficacy in conditions such as spinal cord injury (SCI), where it has shown potential to improve functional recovery. Its ability to attenuate ER stress-stimulated collagen production further highlights its antifibrotic mechanismsOrder directly from ... The synthetic tetrapeptideAc-SDKP(Seraspenide) is involved in angiogenesis and regulation of the immune response by blocking the ....

The Ac-SDKP peptide is a substrate for the angiotensin-converting enzyme (ACE), and its interaction with ACE is crucial for its biological functions and therapeutic potentialAc-SKDP is a pro-angiogenicpeptidedegradation product of thymosin B4 that regulates hematopoiesis by inhibiting proliferation of hematopoietic pluripotent .... The structural basis of Ac-SDKP hydrolysis by Angiotensin-I converting enzyme has been a focus of detailed research, providing insights into its mechanism of action.作者：UC Sharma·2018·被引用次数：37—Conclusions: Our study identifies novel cardioprotective effects ofAc-SDKPin a model of cardiac irradiation. These protective effects are ...

While research into the clinical applications of Ac-SDKP is ongoing, its demonstrated properties suggest potential use in treating:

* Fibrotic diseases affecting organs like the lungs, liver, and kidneys.

* Cardiovascular conditions, including hypertension and post-ischemic heart damageMANP (M-Atrial Natriuretic Peptide) Reduces Blood Pressure and ....

* Inflammatory disorders.

* Conditions involving impaired wound healing or tissue regeneration.

The Ac-SDKP peptide represents a fascinating area of scientific inquiry, offering a glimpse into the body's sophisticated regulatory systems and holding significant promise for future therapeutic advancements. Further research into its precise mechanisms and clinical efficacy will undoubtedly unlock its full potential.